ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
Satishbh
|
186 |
48K |
22 |
12/08/24 |
12/08/24 |
ASX - By Stock
|
186
|
48K
|
22
|
|
ASX - By Stock
|
PAA |
Re:
Ann: OLE Study update reveals impressive Survival Data
|
|
Satishbh
|
248 |
67K |
12 |
09/08/24 |
09/08/24 |
ASX - By Stock
|
248
|
67K
|
12
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race to Present at TechKnow July Conference
|
|
Satishbh
|
132 |
31K |
19 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
132
|
31K
|
19
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race to Present at TechKnow July Conference
|
|
Satishbh
|
132 |
31K |
25 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
132
|
31K
|
25
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race to Present at TechKnow July Conference
|
|
Satishbh
|
132 |
31K |
16 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
132
|
31K
|
16
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race to Present at TechKnow July Conference
|
|
Satishbh
|
132 |
31K |
1 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
132
|
31K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C & Quarterly Update
|
|
Satishbh
|
38 |
8.9K |
6 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
38
|
8.9K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C & Quarterly Update
|
|
Satishbh
|
38 |
8.9K |
6 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
38
|
8.9K
|
6
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Quarterly Activity Report and Appendix 4C
|
|
Satishbh
|
34 |
9.9K |
26 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
34
|
9.9K
|
26
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Satishbh
|
11K |
3.9M |
19 |
22/07/24 |
22/07/24 |
General
|
11K
|
3.9M
|
19
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Satishbh
|
21K |
7.6M |
7 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
21K
|
7.6M
|
7
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
Satishbh
|
978 |
264K |
15 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
978
|
264K
|
15
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Satishbh
|
11K |
3.9M |
22 |
05/07/24 |
05/07/24 |
General
|
11K
|
3.9M
|
22
|
|
ASX - By Stock
|
PAA |
Re:
Ann: OLE Study update reveals impressive Survival Data
|
|
Satishbh
|
248 |
67K |
14 |
05/07/24 |
05/07/24 |
ASX - By Stock
|
248
|
67K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Ann: OLE Study update reveals impressive Survival Data
|
|
Satishbh
|
248 |
67K |
3 |
05/07/24 |
05/07/24 |
ASX - By Stock
|
248
|
67K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race In-person Investor Briefing Invitation Perth
|
|
Satishbh
|
130 |
36K |
12 |
04/07/24 |
04/07/24 |
ASX - By Stock
|
130
|
36K
|
12
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race In-person Investor Briefing Invitation Perth
|
|
Satishbh
|
130 |
36K |
35 |
04/07/24 |
04/07/24 |
ASX - By Stock
|
130
|
36K
|
35
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
Satishbh
|
978 |
264K |
13 |
02/07/24 |
02/07/24 |
ASX - By Stock
|
978
|
264K
|
13
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
Satishbh
|
2.2K |
765K |
23 |
02/07/24 |
02/07/24 |
ASX - By Stock
|
2.2K
|
765K
|
23
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
Satishbh
|
978 |
264K |
6 |
02/07/24 |
02/07/24 |
ASX - By Stock
|
978
|
264K
|
6
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
Satishbh
|
978 |
264K |
13 |
02/07/24 |
02/07/24 |
ASX - By Stock
|
978
|
264K
|
13
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Distinguished Oncologist Daniel Von Hoff Joins as Consultant
|
|
Satishbh
|
168 |
47K |
27 |
02/07/24 |
02/07/24 |
ASX - By Stock
|
168
|
47K
|
27
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Application for quotation of securities - RAC
|
|
Satishbh
|
8 |
2.8K |
18 |
27/06/24 |
27/06/24 |
ASX - By Stock
|
8
|
2.8K
|
18
|
|
ASX - By Stock
|
RAC |
Re:
Ann: RC220 GLP Non-clinical Toxicology Program Successful
|
|
Satishbh
|
80 |
25K |
17 |
26/06/24 |
26/06/24 |
ASX - By Stock
|
80
|
25K
|
17
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
Satishbh
|
978 |
264K |
14 |
26/06/24 |
26/06/24 |
ASX - By Stock
|
978
|
264K
|
14
|
|
ASX - By Stock
|
RAC |
Re:
Ann: RC220 GLP Non-clinical Toxicology Program Successful
|
|
Satishbh
|
80 |
25K |
24 |
26/06/24 |
26/06/24 |
ASX - By Stock
|
80
|
25K
|
24
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
Satishbh
|
2.9K |
1.0M |
9 |
24/06/24 |
24/06/24 |
ASX - By Stock
|
2.9K
|
1.0M
|
9
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
Satishbh
|
2.9K |
1.0M |
10 |
24/06/24 |
24/06/24 |
ASX - By Stock
|
2.9K
|
1.0M
|
10
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Satishbh
|
21K |
7.6M |
24 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
21K
|
7.6M
|
24
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Satishbh
|
21K |
7.6M |
8 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
21K
|
7.6M
|
8
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Satishbh
|
21K |
7.6M |
20 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
21K
|
7.6M
|
20
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
Satishbh
|
2.2K |
765K |
20 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
2.2K
|
765K
|
20
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
Satishbh
|
146 |
42K |
24 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
146
|
42K
|
24
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
Satishbh
|
159 |
40K |
2 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
159
|
40K
|
2
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Satishbh
|
11K |
3.9M |
10 |
14/06/24 |
14/06/24 |
General
|
11K
|
3.9M
|
10
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Satishbh
|
21K |
7.6M |
16 |
12/06/24 |
12/06/24 |
ASX - By Stock
|
21K
|
7.6M
|
16
|
|
ASX - By Stock
|
DXB |
Re:
DXB - Research & Valuation
|
|
Satishbh
|
230 |
108K |
21 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
230
|
108K
|
21
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Executive team strengthened, appointment of MD/CEO & new CSO
|
|
Satishbh
|
85 |
22K |
13 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
85
|
22K
|
13
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Application for quotation of securities - RAC
|
|
Satishbh
|
126 |
31K |
17 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
126
|
31K
|
17
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Application for quotation of securities - RAC
|
|
Satishbh
|
126 |
31K |
10 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
126
|
31K
|
10
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Satishbh
|
21K |
7.6M |
14 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
21K
|
7.6M
|
14
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene with Decitabine Enhances Cancer Cell Killing
|
|
Satishbh
|
104 |
32K |
10 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
104
|
32K
|
10
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene with Decitabine Enhances Cancer Cell Killing
|
|
Satishbh
|
104 |
32K |
15 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
104
|
32K
|
15
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene with Decitabine Enhances Cancer Cell Killing
|
|
Satishbh
|
104 |
32K |
40 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
104
|
32K
|
40
|
|
ASX - By Stock
|
RAC |
Re:
Ann: RAC Investor Presentation May 2024
|
|
Satishbh
|
55 |
16K |
13 |
13/05/24 |
13/05/24 |
ASX - By Stock
|
55
|
16K
|
13
|
|
ASX - By Stock
|
RAC |
Re:
Corporate Spotlight Advertisement.on HC
|
|
Satishbh
|
37 |
11K |
6 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
37
|
11K
|
6
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Satishbh
|
21K |
7.6M |
17 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
21K
|
7.6M
|
17
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Satishbh
|
21K |
7.6M |
35 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
21K
|
7.6M
|
35
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Satishbh
|
905 |
266K |
20 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
905
|
266K
|
20
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
Satishbh
|
2.2K |
765K |
15 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
2.2K
|
765K
|
15
|
|